Precision Oncology Market Size

Precision Oncology Market size was over USD 116.53 billion in 2024 and is anticipated to cross USD 397.56 billion by 2037, growing at more than 9.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of precision oncology is estimated at USD 125.76 billion. Advances in genomic sequencing technologies are a primary driver of progress in precision oncology.

The ongoing development of sequencing techniques has transformed the ability to comprehend tumors' complex genetic makeup providing oncologists with unparalleled insights for customized cancer treatment. Increasing understanding of disease mechanisms and allowing the identification of the distinct molecular markers for disease subtypes, as a result, medical professionals can treat individuals according to their features. As per a recent survey, 55 % of the patients had a survival of three years who received personalized cancer therapy as compared to 25 % of patients who received therapy with low degrees of matching.